Low MOQ for Doxycycline Hyclate Capsules - Rosuvastatin Calcium – CPF
Low MOQ for Doxycycline Hyclate Capsules - Rosuvastatin Calcium – CPF Detail:
瑞舒伐他汀钙 | Rosuvastatin Calcium | 147098-20-2 | In-House/CEP |
RSM(Crystal) | 147118-40-9 | In-House | |
RSM(Crude) | 147118-40-9 | In-House | |
RSP | — | In-House | |
RS-8 | 147118-36-3 | In-House | |
RS-8-1 | 147118-37-4 | In-House | |
TP-8 | 131466-61-0 | In-House | |
TP-11 | 147118-35-2 | In-House | |
TP-13 | 147118-39-6 | In-House | |
RS-10 | 289042-12-2 | In-House | |
RS-11 | 355806-00-7 | In-House |
Description
Rosuvastatin Calcium (BANM, JAN, USAN) is known as Rosuvastatin in the US. and a competitive HMG-CoA reductase inhibitor with an IC50 of 11 nM[1]. Rosuvastatin Calcium potently blocks human ether-a-go-go related gene (hERG) current with an IC50 of 195 nM, delayed cardiac repolarization, and thereby prolonged action potential durations (APDs) and corrected QT interval (QTc) intervals[2]. Rosuvastatin Calcium reduces the expression of the mature hERG and the interaction of heat shock protein 70 (Hsp70) with the hERG protein. Rosuvastatin Calcium is very effective in lowering low-density lipoprotein (LDL) cholesterol, triglycerides, and C-reactive protein levels[3].
Further information on drug naming conventions: International Nonproprietary Names.
Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.
In the US, Rosuvastatin (rosuvastatin systemic) is a member of the drug class statins and is used to treat Atherosclerosis, High Cholesterol, High Cholesterol – Familial Heterozygous, High Cholesterol – Familial Homozygous, Hyperlipoproteinemia, Hyperlipoproteinemia Type IIa – Elevated LDL, Hyperlipoproteinemia Type IIb – Elevated LDL VLDL, Hyperlipoproteinemia Type III – Elevated beta-VLDL IDL, Hyperlipoproteinemia Type IV – Elevated VLDL, Hypertriglyceridemia and Prevention of Cardiovascular Disease.
Background
A selective, competitive inhibitor of HMG-CoA reductase, that is also antilipemic.
Storage
Powder |
-20°C |
3 years |
4°C |
2 years | |
In solvent |
-80°C |
6 months |
-20°C |
1 month |
Chemical structure
Proposal 18 Quality Consistency Evaluation projects which have approved 4, and 6 projects are under approving.
Advanced international quality management system has laid solid foundation for sales.
Quality supervision runs through the whole life cycle of the product to ensure the quality and therapeutic effect.
Professional Regulatory Affairs team supports the quality demands during the application and registration.
VIEW MORE
VIEW MORE
International cooperation
Domestic cooperation
Product detail pictures:
Related Product Guide:
We support our prospective buyers with ideal top quality merchandise and superior level provider. Becoming the specialist manufacturer in this sector, we have now attained abundant practical expertise in producing and managing for Low MOQ for Doxycycline Hyclate Capsules - Rosuvastatin Calcium – CPF , The product will supply to all over the world, such as: Washington, Swedish, Nepal, Customer satisfaction is our first goal. Our mission is to pursue the superlative quality, making continual progress. We sincerely welcome you to make progress hand in hand with us, and construct a prosperous future together.
By Eric from Germany - 2018.07.12 12:19
Company director has very rich management experience and strict attitude, sales staff are warm and cheerful, technical staff are professional and responsible,so we have no worry about product,a nice manufacturer.
By Diego from Sheffield - 2017.06.25 12:48